Ruga Corporation

Targeting Tumor-Selective Adaptive Responses

About

About

Team

Team

Technology

Technology

Programs

Programs

Pipeline

Pipeline

Partnerships

Partnerships

News

News

Publications

Pubs
Contact Contact
Ruga Corporation

STRATEGIC INITIATIVES

Program 1
Endoplasmic Reticulum Stress and Unfolded Protein Response

Program 2
Tumor Metabolism
Program 3
Tumor Microenvironment
Program 4
Autophagy
Program 5
Drug Adaptation
Program 6
Research and Target Discovery
Ruga Corporation is an innovative private biopharmaceutical company that discovers and develops novel targeted therapeutics in oncology, focusing on tumor metabolism and endoplasmic reticulum stress pathways. Ruga is dedicated to bringing fundamental biological insights to the clinic, addressing major unmet clinical needs in order to transform personalized oncology therapeutics and enhance the lives of cancer patients.

info@rugacorp.com

© 2012, Ruga Corporation.

phone: • fax: